Tag

NASDAQ: CGEM

Cullinan Therapeutics gains FDA clearance for velinotamig blood-disorder trial
Adrian Kessler · Oct 27, 2026
Cullinan Therapeutics begins FDA submission for zipalertinib combination
Adrian Kessler · Oct 2, 2026